Search

Author/Creator Sparrow, M

1. DOP49 Efficacy of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) antibody SHP647 in ulcerative colitis: results from the open-label extension study TURANDOT II. (25th January 2019)

Authors:
Reinisch, W; Sandborn, W J; Danese, S; Hébuterne, X; Kłopocka, M; Tarabar, D; Vaňásek, T; Greguš, M; Hellstern, P A; Kim, J S; Sparrow, M; Gorelick, K J; Goetsch, M; Bliss, C; Gupta, C; Cataldi, F; Vermeire, S
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S056
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. DOP51 Biomarker and pharmacokinetic data from the TURANDOT II open-label extension study of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) antibody SHP647 in patients with ulcerative colitis. (25th January 2019)

Authors:
Reinisch, W; Sandborn, W J; Danese, S; Hébuterne, X; Kłopocka, M; Tarabar, D; Vaňásek, T; Greguš, M; Hellstern, P A; Kim, J S; Sparrow, M; Gorelick, K J; Goetsch, M; Bliss, C; Gupta, C; Cataldi, F; Vermeire, S
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S058
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P428 Pharmacist-led proactive therapeutic drug monitoring with infliximab (PROXIMO): Utility of and cost-saving associated with the use of a rapid assay for assessing drug level. (16th January 2018)

Authors:
Rentsch, C; Sparrow, M; Ward, M; Taylor, K; Friedman, A; Luber, R; Su, H; Hopkins, R; Head-on, B; Dooley, M; Gibson, P
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S321
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P551 6-Thioguanine nucleotide levels are associated with mucosal healing in patients with Crohn's disease: A multi-centre, international study. (16th January 2018)

Authors:
Mao, R; Guo, J; Luber, R; Chen, B -l; He, Y; Zeng, Z -r; Ben-Horin, S; Sparrow, M; Xavier, R; Chen, M -h
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S384
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P571 Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC). (16th January 2018)

Authors:
Pulusu, S S R; Srinivasan, A; Krishnaprasad, K; Cheng, D; Mogilevski, T; Flanagan, E; Keung, C; Wu, C; Prosser, R; Sawyer, E; Rizvi, Q -U -A; Su, H; Leung, W -K; Edmundson, A; Cooke, S; Mahy, G; Thin, L; Radford-Smith, G; Sparrow, M; Andrews, J M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S395
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P709 Is there a difference in adalimumab drug levels according to pen vs. syringe use: An international, multi-centre retrospective analysis. (16th January 2018)

Authors:
Little, R; Chu, I; van der Zanden, E; Flanagan, E; Bell, S; Sparrow, M; Shelton, E; Connor, S; Roblin, X; Ward, M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S469
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. P764 Drug level thresholds in patients with Crohn's disease on dose-intensified anti-TNF therapy predict intestinal wall healing for infliximab but not adalimumab. (16th January 2018)

Authors:
Little, R; Su, H; Friedman, A; Williams, S; Gibson, P; Ward, M; Taylor, K; Sparrow, M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S497
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗